Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion: more data required

被引:0
|
作者
K Hu
S E Horgan
R R Sivaraj
K Avgikos
机构
[1] Moorfields Eye Hospital NHS Foundation Trust at St George's Hospital,Department of Ophthalmology
[2] London,undefined
[3] UK. E-mail: kuanghu@kuanghu.com,undefined
来源
Eye | 2010年 / 24卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:194 / 194
相关论文
共 50 条
  • [1] Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion: more data required
    Hu, K.
    Horgan, S. E.
    Sivaraj, R. R.
    Avgikos, K.
    EYE, 2010, 24 (01) : 194 - 194
  • [2] Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion
    Guenduez, K.
    Bakri, S. J.
    EYE, 2008, 22 (09) : 1168 - 1171
  • [3] Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion
    K Gündüz
    S J Bakri
    Eye, 2008, 22 : 1168 - 1171
  • [4] Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion
    Kreutzer, T. C.
    Alge, C. S.
    Wolf, A. H.
    Kook, D.
    Burger, J.
    Strauss, R.
    Kunze, C.
    Haritoglou, C.
    Kampik, A.
    Priglinger, S.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (03) : 351 - 355
  • [5] INTRAVITREAL BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION
    Ehlers, Justis P.
    Decroos, Francis Char
    Fekrat, Sharon
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (09): : 1856 - 1862
  • [6] Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion
    Cheng, K-C
    Wu, W-C
    Chen, K-J
    EYE, 2009, 23 (11) : 2024 - 2032
  • [7] Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion
    K-C Cheng
    W-C Wu
    K-J Chen
    Eye, 2009, 23 : 2023 - 2033
  • [8] Intravitreal Injection of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
    Zucchiatti, I.
    Savorgnani, C.
    Veritti, D.
    Parodi, M. Battaglia
    Kontadakis, D. S.
    Papayannis, A.
    Iacono, P.
    Lanzetta, P.
    Bandello, F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [9] Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion
    Hikichi, Taiichi
    Higuchi, Makoto
    Matsushita, Takuro
    Kosaka, Shoko
    Matsushita, Reiko
    Takami, Kinnitaka
    Ohtsuka, Hideo
    Kitamei, Hirokuni
    Shioya, Shoko
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (02) : 195 - 199
  • [10] Intravitreal Bevacizumab (IVB) for Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
    Azhar, Muhammad Naeem
    Muzaffar, Waqar
    Arain, Muhammad Aamir
    Farooq, Omer
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (10): : 758 - 761